The costs and benefits of an early access scheme for oncology medicines in Ireland
{{output}}
Background: Access to new oncology medicines is subject to delays in many countries due to lengthy appraisal processes. This study examines the cost to the Irish healthcare system of implementing a cost-sharing agreement to exped... ...
